+ 0.40
+ 0.12%
+ 1.41
+ 0.41%
+ 1.40
+ 0.34%
+ 1.00
+ 0.6%

Bulls And Bears Of The Week: Abbott Labs, Chevron, CVS, United And More

April 20, 2019 4:44 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Benzinga has examined prospects for many investor favorite stocks over the past week.

Bullish calls included a leading airline and a pharmaceutical giant.

And bearish calls included cruise line operators and two retailers.

In a holiday-shortened week in which a huge merger deal seemed to fall apart, two tech giants settled a long-running dispute and a Paris landmark suffered a catastrophe, perhaps the biggest news was the release of the long-awaited Mueller report.

Otherwise, first-quarter earnings results have been solid overall and economic data seems to show a U.S. economy treading water. The big three U.S. indexes ended the week nearly flat, though still not far off their all-time highs.

Benzinga continues to examine the prospects for many investor favorite stocks. The following are just a few of this past week's most bullish and bearish posts that may be worth another look.


See which top analyst called the latest Chevron Corporation (NYSE:CVX) acquisition a "win-win" deal for shareholders, according to Wayne Duggan's "Wall Street Weighs In On Chevron Following Anadarko Deal."

"Buckingham Lifts United Continental Outlook, Price Target After Q1 Beat" by Priya Nigam discusses why the prospects for United Continental Holdings Inc (NYSE:UAL) look good despite the Boeing Co (NYSE:BA) 737 MAX grounding. 

Shanthi Rexaline's "An Abbott Labs Analyst's 5 Reasons To Own The Stock: 'Near-Perfect For This Environment'" shows why there are far more reasons to own Abbott Laboratories (NYSE:ABT) stock than not in one analyst's view. 

In "A Few Key Takeaways From Cowen's Off-Price Retail Store Visits," Brett Hershman shows what channel checks suggest about the prospects of TJX Companies Inc (NYSE:TJX) and some of its peers. 

For additional bullish calls, also have a look at "3 Reasons Imperial Capital Is More Bullish On Disney" and "RBC Bullish On New Dow, Less So On DowDupont."


"Oppenheimer Joins Chorus Of CVS Analysts Cautious On Near-Term Outlook" by Shanthi Rexaline discusses why one key analyst has stepped to the sidelines on CVS Health Corp (NYSE:CVS).

In Dave Royce's "Cruise Line Stocks Fall As Trump Administration Tightens Restrictions On Cuba, Venezuela," see how Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) and others may be affected by new travel rules.

Priya Nigam's "Raymond James Downgrades Comerica, Says Q1 Report Not As Good As It Looks" shows why one analyst was not impressed by the latest Comerica Incorporated (NYSE:CMA) earnings beat.

One key analyst stopped short of recommending shorting Pier 1 Imports Inc (NYSE:PIR) stock but expects it to underperform. So says "Pier 1 Falls Off The Deep End With 'Distressing' Q4 Report" by Elizabeth Balboa.

Be sure to check out "Is JB Hunt's Q1 Miss A 'Reality Check' For The Sector? The Street Debates" and "RBC Upgrades Marathon, Downgrades BP" for additional bearish calls.

At the time of this writing, the author had no position in the mentioned equities.

Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.


Trading Ideas

Related Articles

The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs

Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American Association of Cancer Research's annual meeting provided a platform for oncology-focused biopharma companies to present data from their clinical programs. read more

3 Stocks Near 52-Week Lows That Could Bounce Back

After the sell-off in February, the markets have sprung back up. The broader S&P 500 Index is trading at an all-time high and the blue-chip Dow Jones Industrial Index is just shy of its all-time peak. read more

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week. Biotechs, REITs and a car rental leader saw notable insider purchasing of shares. read more

Market On Open Imbalances: Bank Of America: 1.3M Shares To Sell; Exxon Mobil: 200K Shares To Sell; Abbott: 85K Shares To Sell; Wells Fargo: 200K Shares To Sell; AT&T: 233K Shares To Sell